Literature DB >> 28844392

Lazarus Syndrome With Crizotinib in a Non-Small Cell Lung Cancer Patient With ROS1 Rearrangement and Disseminated Intravascular Coagulation.

Solenn Brosseau1, Valérie Gounant1, Charles Naltet1, Nathalie Théou-Anton2, Aurélie Cazes3, Roland Smonig4, Mathilde Neuville4, Antoine Khalil5, Nidaa Mikail6, Véronique Meignin7, Anne Bergeron8, Gérard Zalcman9.   

Abstract

Entities:  

Keywords:  Crizotinib; DIC; Intensive care; NSCLC; ROS1

Mesh：

Substances：

Year:  2017        PMID： 28844392     DOI： 10.1016/j.cllc.2017.07.003

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN： 1525-7304            Impact factor:   4.785


× No keyword cloud information.
  2 in total

1.  Systemic thromboembolism from a misdiagnosed non-bacterial thrombotic endocarditis in a patient with lung cancer: A case report.

Authors:  Fabiana Perrone; Andrea Biagi; Francesco Facchinetti; Francesca Bozzetti; Andrea Ramelli; Antonella Vezzani; Tullio Manca; Letizia Gnetti; Maria Majori; Veronica Alfieri; Marcello Tiseo
Journal:  Oncol Lett       Date:  2020-09-03       Impact factor: 2.967

Review 2.  Disseminated intravascular coagulation complicating diagnosis of ROS1-mutant non-small cell lung cancer: A case report and literature review.

Authors:  Rachel Woodford; Michel Lu; Nadine Beydoun; Wendy Cooper; Qin Liu; Jodi Lynch; Lawrence Kasherman
Journal:  Thorac Cancer       Date:  2021-07-22       Impact factor: 3.500
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.